LegaLogic Consulting advised Intox in share sale transaction with Aragen Life Sciences
LegaLogic Consulting advised Intox (http://www.intoxlab.com) in share sale transaction with Aragen Life Sciences ( www.aragen.com)
Intox is a reputed GLP certified pre-clinical contract research organization (CRO) with its test facilities in Pune, India. It has conducted more than 15,000 GLP studies for global clients which include large and mid-sized customers across pharmaceuticals, biopharmaceuticals, plant protection, nutraceuticals, and medical devices.
Aragen Life Sciences (Formerly GVKB Biosciences) is a large global research, development, and manufacturing solutions provider, with investment from Goldman Sachs. This acquisition will expand Aragen’s end-to-end integrated discovery and development platform for the pharmaceuticals, biotechnology, animal health and agrochemicals industries.
https://www.businesswire.com/news/home/20211214005816/en/Aragen-Acquires-Intox-Pvt.-Ltd. / https://www.aragen.com/news/aragen-acquires-intox-pvt-ltd/
LegaLogic (www.LegaLogic.co.in) was the sole legal counsel for Intox and advised on negotiation and finalization of deal documentation, assistance on due diligence and closing of the transaction.
